6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine,
cebranopadol,
Cebranopadol,
863513-91-1,
GRT6005,
UNII-7GDW9S3GN3,
GRT 6005,
7GDW9S3GN3,
Cebranopadol [USAN:INN],
GRT-6005,
Cebranopadol (USAN/INN),
Cebranopadol(GRT-6005),
863513-93-3,
SCHEMBL154336,
SCHEMBL566256,
GTPL8866,
CHEMBL2364605,
CHEMBL3545616,
CHEMBL3962932,
SCHEMBL10035739,
SCHEMBL14183935,
SCHEMBL19336241,
BDBM177926,
BCP09612,
EX-A1095,
ZINC3950145,
BDBM50101095,
BDBM50101112,
Cebranopadol (1|A,4|A)stereoisomer,
AKOS025290738,
AKOS032953927,
CS-1323,
DB12830,
SB16531,
NCGC00378895-01,
AK170452,
AS-35183,
HY-15536,
Spiro(cyclohexane-1,1'(3'h)-pyrano(3,4-b)indol)-4-amine, 6'-fluoro-4',9'-dihydro-n,N-dimethyl-4-phenyl-, trans-,
trans-6'-Fluoro-n,N-dimethyl-4-phenyl-4',9''-dihydro-3'h-spiro(cyclohexane-1,1'-pyrano(3,4-b)indol)-4-amine,
A3296,
KS-00000632,
A12670,
D10436,
W-6094,
US9120797, 24,
US9120797, 25,
(1r,4r)-6'-Fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine,
(1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4-b]indole]-4-amine,
6-Fluoro-N,N-dimethyl-1'-phenyl-spiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine,
6-fluoro-N,N-dimethyl-1'-phenylspiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine,
Cebranopadol [INN],
D03TBJ,
D0R4YE,
CHEMBL3325957,
CHEMBL3325958,
CID11848225,
GRT 6005/06,
CID 11848225,
Centrally-acting nociceptin agonist analgesic (oral liquid, pain/diabetic neuropathy), Grunenthal,
spiro[cyclohexane-1,1'(3'h)-pyrano[3,4-b]indol]-4-amine, 6'-fluoro-4',9'-dihydro-n,n-dimethyl-4-phenyl-, (1a,4)-,
Spiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-amine, 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenyl-, cis- (9CI),